Comparison of frequency of hemorrhagic stroke in patients <75 years versus ≥75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions
- 1 February 2004
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 93 (3), 346-349
- https://doi.org/10.1016/j.amjcard.2003.10.018
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Survival After Coronary Revascularization in the ElderlyCirculation, 2002
- Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenariansJournal of the American College of Cardiology, 2000
- Long-term clinical events following creatine kinase–myocardial band isoenzyme elevation after successful coronary stentingJournal of the American College of Cardiology, 2000
- Atherosclerotic Plaque Burden and CK-MB Enzyme Elevation After Coronary InterventionsCirculation, 2000
- Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularizationAmerican Heart Journal, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 1998
- Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary AngioplastyCirculation, 1997
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineThe New England Journal of Medicine, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyThe New England Journal of Medicine, 1994
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987